Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Development of a Novel Patient-reported Outcome Measure of Functional Impacts for Narcolepsy Types 1 and 2

Author:Romero, Heather   Savva, Yulia   Crawford, Stephen   McPherson, Peter   Doll, Helen   Howerter, Amy   Symonds, Tara   Swick, Todd   Dauvilliers, Yves   

Session Name:P8: Sleep 2  

Topic:Sleep  

Program Number:P8.003  

Author Institution:Takeda Development Center Americas, Inc., Cambridge, MA  Clinical Outcomes Solutions, Folkstone, United Kingdom  Clinical Outcomes Solutions, Tuscon, AZ  Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, University of Montpelier, Montpellier, France  

Mechanisms of Electroconvulsive Therapy to Improve Depressive Symptoms and Sleep Regulation Based on the Microbial Gut-brain Axis

Author:Ji, Jiaming   Chen, Chaojin   

Session Name:P8: Aging, Dementia, and Behavioral Neurology: Non-AD Treatments  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P8.003  

Author Institution:the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, People's Republic of  

Ocrelizumab Subcutaneous Administration: Further Characterization of the Benefit–Risk Profile from the OCARINA II Study and Patient Preferences

Author:Newsome, Scott   Goldstick, Lawrence   Selmaj, Krzysztof   Krzystanek, Ewa   Zecevic, Dusanka   Figueiredo, Catarina   Clinch, Susanne   Giacobino, Caroline   Azmi, Jay   Centonze, Diego   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.003  

Author Institution:Johns Hopkins University School of Medicine, Baltimore, MD, USA, Baltimore, MD  Department of Neurology and Rehabilitation Waddell Center for Multiple Sclerosis, University of Cincinnati, College of Medicine, Cincinnati, OH, USA, Cincinnati, OH  Centrum Neurologii, Lódz, Poland, Lódz, Poland  Department of Neurology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland, Katowice, Poland  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy, Rome, Italy  

Long-term Function and Survival of Radicava ORS® (Oral Edaravone)-Treated Patients With ALS vs Propensity Score–Matched PRO-ACT Historical Controls

Author:Takahashi, Fumihiro   Genge, Angela   Yoneoka, Takatomo   Hirai, Manabu   Selness, Daniel   Todorovic, Vesna   Wamil, Art   Sasson, Nissim   Apple, Stephen   Yoshiteru, Ushirogawa   

Session Name:P8: General Neurology: Motor Neuron Disease 1  

Topic:General Neurology  

Program Number:P8.003  

Author Institution:Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Montreal Neurological Institute and Hospital, Montreal, QC, Canada  Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan  Mitsubishi Tanabe Pharma Europe, Ltd, London, United Kingdom  NStat Solutions, Biostatistical Services, Rehovot, Israel  

First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Focal Epilepsy - Updated Clinical Trial Results

Author:Hixson, John   Spencer, David   Burchiel, Kim   Babu, Harish   Beach, Robert   Shih, Jerry   Ben-Haim, Sharona   O'Dwyer, Rebecca   Sani, Sepehr   Southwell, Derek   Luedke, Matthew   Blum, David   Banik, Gautam   Bershteyn, Marina   Bulfone, Alessandro   Feld, Brianna   Finefrock, Holl   

Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P8.003  

Author Institution:Neurona Therapeutics, South San Francisco, CA  OHSU, Portland, OR  SUNY Syracuse, Syracuse, NY  UC San Diego Health, La Jolla, CA  Rush University Medical Center, Chicago, IL  Duke University, Durham, NC  Duke University Hospital Dept. of Neurology, Durham, NC  Neurona Therapeutics, Santa Barbara, CA  Neurona Therapeutics, Redwood City, CA  Neurona Therapeutics, Menlo Park, CA